Harry Cassin Publisher and Editor

Andy Spalding Senior Editor

Jessica Tillipman Senior Editor

Richard L. Cassin Editor at Large

Elizabeth K. Spahn Editor Emeritus 

Cody Worthington Contributing Editor

Julie DiMauro Contributing Editor

Thomas Fox Contributing Editor

Marc Alain Bohn Contributing Editor

Bill Waite Contributing Editor

Shruti J. Shah Contributing Editor

Russell A. Stamets Contributing Editor

Richard Bistrong Contributing Editor 

Eric Carlson Contributing Editor

Bill Steinman Contributing Editor

Aarti Maharaj Contributing Editor

FCPA Blog Daily News

« Cool Deal For Summer | Main | Facilitating Payments (De)Mystified, Redux »

Resource Alert: China Pharma, Medical News

China Compliance Digest: Rx Edition is a weekly compendium of recent news stories about corruption and enforcement in China's pharmaceutical and medical industries.

This newsletter was designed to provide an insider's view of the compliance challenges experienced by foreign companies working within these industries in China. In addition, our coverage will alert you to emerging risks and potentially compromising situations as they evolve.

Our writers scour Chinese-language sources to bring you timely information on issues rarely covered in the Western media.

The inaugural issue of China Compliance Digest: Rx Edition compiles relevant stories that have appeared in the newsletter over the past few months. New information has been added to bring the stories up to date.

Click now for a free trial subscription:


Reader Comments

There are no comments for this journal entry. To create a new comment, use the form below.

PostPost a New Comment

Enter your information below to add a new comment.

My response is on my own website »
Author Email (optional):
Author URL (optional):
All HTML will be escaped. Hyperlinks will be created for URLs automatically.